Outset Medical vs Sanara Medtech
Outset Medical is the larger business, with $119m of revenue in fiscal 2025 against $103m for Sanara Medtech (1.2 times as much). Sanara Medtech grew faster (19.0% against 5.1%). Sanara Medtech kept more of each dollar of sales as profit: a net margin of -36.4% against -68.3%. Outset Medical carries less debt relative to equity (75.8% against 790.2%).
| Latest fiscal year | Outset MedicalOM, 2025 | Sanara MedtechSMTI, 2025 |
|---|---|---|
| Revenue | $119m | $103m |
| Revenue growth | 5.1% | 19.0% |
| Net income | −$81.7m | −$37.6m |
| Operating margin | -55.8% | 7.1% |
| Net margin | -68.3% | -36.4% |
| Return on equity | -106.2% | -165.7% |
| Free cash flow | −$47.1m | $2.2m |
| Cash | $35.0m | $16.6m |
| Total debt | $96.2m | $46.9m |
| Debt to equity | 75.8% | 790.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 254 | 108 |
| Market value | $75.6m | $295m |
| Price vs our value range | — | — |
| Moat score | 12 (Weak) | 34 (Weak) |
| Insider trades, 12 months | 2 buys, 23 sales | 0 buys, 0 sales |